
Medical
A new frontier in medicine: MGC Pharma discusses drug delivery innovation
MGC Pharma is hoping to bring more surprises to the market in the next few years.

MGC Pharma is hoping to bring more surprises to the market in the next few years.

The agreements follow its post-IPO review after its £16.5m fundraise and admission to the main market on LSE in May this year.

India Globalization hopes the formula could provide relief for the potential 50 million people across the globe which are expected to be impacted by Alzheimer’s disease by 2030

The partnership will help to accelerate and advance research for both cannabis and psychedelics.

The Apollon medical cannabis formulations are an opportunity for more men to have their prostate cancer treated.

MGC Pharmaceuticals is preparing to move forward with novel, unique and disruptive research in the medical cannabis sector after securing